drugset / Trial / NCT01313143

A Short Term Pharmacokinetic, Pharmacodynamic and Tolerability Study to Compare AOP200704 vs. Esmolol

NCT01313143

Phase 2 Completed 16 enrolled AOP Orphan Pharmaceuticals AG
RandomizedCrossoverTriple-blindTreatment

Summary

Pharmacokinetics, pharmacodynamics and tolerability of AOP200704 infusion is compared to that of Esmolol by measurement of plasma concentrations of AOP200704, esmolol and their metabolites, by assessing the effect of both drugs on dobutamine-induced tachycardia, and by monitoring vital signs, ECG and adverse events.

Timeline

Start
2011-03
Primary completion
2011-05
Completion
2012-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Esmolol Other / unclassified Other
Subject Landiolol Small molecule Other

Indications

No indication recorded.